ZENG Qingwen, an in office attending physician, and genetic counselor. Dr. Zeng received his PhD degree in Genomics from East China Normal University in 2012. Before joining JIH, Dr. Zeng worked for 8 years in Shanghai Jiao Tong University affiliated Pediatric Medical Research Institute of Xinhua Hospital and subsequently in PerkinElmer, and specified in clinical molecular diagnosis and genetic counseling, where he completed more than 2000 clinical next-generation data analyses and genetic counseling cases. In 2016, he obtained a certificate in prenatal diagnosis technology from Shanghai Municipal Health and Family Planning Commission. From 2020 to 2021, he participated in, and completed the fifth International Clinical Genetics and Genetic Counseling training course jointly organized by the China Eugenics Science Association, Chinese University of Hong Kong of Peking Union Medical College Hospital, and Baylor College of Medicine. He has presided over and completed a National Natural Science Foundation project in China and one provincial and ministerial fund project .Last but not least, he published more than 10 SCI papers.

Practice certificate code: 110320500020755

Dr. Jennet LIU is the attending physician in Critical Care Medicine.

Dr. Liu graduated from Shanghai Jiaotong University School of Medicine (formerly Shanghai Second Medical University) with a master's degree in clinical medicine. She completed her internship and residency training at Renji Hospital and Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine respectively. In 2010, she was certified the "First Aid Trauma Certificate" from the Rotterdam Trauma Center of the Erasmus University Medical Center in the Netherlands. In 2016, as the winner of Ugentheum Award, Auscalup Academy, German, she worked as the fellow of BICU, BGU, Ludwigshafen, German. In 2017, Dr. Liu served as visiting scholar in BICU Beverjik Burn Center, Red Cross Hospital, Netherlands. And in 2020, she was nominated by National Health Commission of People’s Republic of China as ICU team member for Public Health Events. Before joining Jiahui, she worked as the Attending Physician in the Burn Intensive Care Unit of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, and an aviation rescue physician in Shanghai HEMS, Base Hospital. Dr. Liu has rich experience in clinical treatment of critically ill patients for more than 20 years, focusing on the comprehensive treatment of patients with severe burns, trauma, complicated skin and soft tissue infections, and the maintenance of organ function in patients with sepsis.

Dr. Liu holds the 5C Critical Care Specialist Qualification Certificate issued by the Critical Care Medicine Branch of the Chinese Medical Association, and the HEMS professional training certificate approved by the Prague Emergency Center in the Czech Republic.

Dr. Liu is certified in Basic Life Support (BLS) and Advanced Cardiac Life Support (ACLS) by American Heart Association (AHA).

Dr. DENG Fangfei is currently an attending Hospitalist of Jiahui International Hospital. Dr. Deng obtained her Master’s degree from Tongji University in 2014. She then completed her residency training at Shanghai Changhai hospital. Prior to joining Jiahui, she went on to complete Nephrologist fellowship training at Shanghai Changhai hospital. In 2020, Dr. Deng joined Jiahui as a fellow of “Renji - Jiahui Hospitalist training program”. During the one-year training, she focused on learning of patient-centered care, evidence-based medicine, medical safety, and quality in the inpatient setting. Dr. Deng is familiar with patient care in area of internal medicine and perioperative management. She has dedicated her work to provide high-quality patient centered medical care.

Dr. Deng is also certified in Basic Life Support (BLS) and Advanced Cardiac Life Support (ACLS) by American Heart Association (AHA). She also obtained ECFMG certificate sponsored by ECFMG. 

 Dr. JI Qinghai is currently the specially-invited consultant of General Surgery Department of Jiahui Health. Dr. Ji graduated from Shanghai Medical University in 1983 and received his master's degree in Clinical Medicine from Shanghai Medical University in 1993. He was the Chief of Head & Neck Surgery Department at Fudan University Shanghai Cancer Center, the chief expert and the convenor of the multidisciplinary comprehensive treatment group of Head & Neck Cancer at Fudan University Shanghai Cancer Center. Dr. Ji Qinghai is the vice Chairman of the Thyroid Cancer Committee of the Chinese Anti-Cancer Association, the vice chairman of the thyroid Cancer Committee of the Chinese Medical Doctor Association, the chairman of the Thyroid Cancer Committee of the Shanghai Anti-Cancer Association, and the leader of the Thyroid Science Group of the General Surgery Committee of the Shanghai Medical Association. Member of Standing Committee of Head & Neck Tumor Professional Committee of China Anti-Cancer Association and former chairman of Head & Neck Tumor Professional Committee of Shanghai Anti-Cancer Association.

He is the editoiral board member of Chinese Journal of Otolaryngology -- Head & Neck Surgery, Chinese Journal of Surgery, Chinese Journal of Cancer, Journal of Chinese Academy of Medical Sciences, Cancer, Chinese Journal of Cancer, Chinese Medical Journal, Medicine, World Journal of Surgical Oncology, Oncotargets and Therapy.

Dr. Ji has been engaged in head & neck cancer surgery for more than 30 years, focusing on clinical and basic research in the treatment of thyroid, laryngeal, hypopharyngeal and tongue cancers. "Surgical treatment of thyroid cancer invading piriform fossa" won the Clinical Achievement Award of Fudan University. Professor Ji Qinghai has presided over a number of major projects of Shanghai Science and Technology Commission, major basic research projects of Shanghai and top priority projects of Shanghai. He has led the research direction of papillary thyroid cancer in China and committed himself to the formulation of diagnosis and treatment standards for papillary thyroid cancer and the standardized training of thyroid surgeons. Since 2015, he has gone throughout the country to promote the standardization of diagnosis and treatment of thyroid cancer, and the specialization of thyroid surgeon training in China.

Areas of expertise:
Diagnosis and surgical treatment of head & neck tumors, including thyroid, salivary glands, oral tumors and laryngeal and laryngeal cancers.

Dr. Julia LI obtained her medical degree at Shanghai Medical University (now named as Fudan University Shanghai Medical College). She was a faculty member and an assistant professor in Shanghai Medical University before moving to US. She received her psychiatric residency training at St. Elizabeth Medical Center of Boston between 1998-2002. She joined The Permanente Medical Group (TPMG) in Northern California after graduating from the psychiatric residency program, and she had been an attending psychiatrist in Kaiser-Permanente in Northern California between 2002-2022. She has medical license as Physician and Surgeon in the state of California, is a diplomate in the specialty of psychiatry certified by the American Board of Psychiatry and Neurology, and a fellow in American Psychiatric Association. In her 20 years clinical experience in mental health field, she developed particular interest in holistic approach in promoting mind and body wellness. She left Kaiser-Permanente In 2022 to be back to her hometown joining Jiahui Health in Shanghai.

License no. : 沪卫外医批字（2022）第129号

Dr. Ruby ZHOU is a dermatologist at Jiahui Health. Dr. Zhou earned her bachelor degree of Medical Technology from Taiwan National Cheng Kung University and received medical degree of Dermatology and Cypridology from Peking University Health Science Center. She has over ten-year experience of general dermatosis, cosmetic laser and injection treatments for rejuvenation. She formerly worked as a dermatologist at The First Affiliated Hospital of Peking University, The First Affiliated Hospital of Fujian Medical University, Shanghai Landseed International Hospital and BDL-BASILICA Plastic & Cosmetic Center. She is experienced in applying comprehensive treatment to reconstitute youth and healthy skin with botulinum toxin, hyaluronic acid filler, chemical peeling, thread lifting and cosmetic techniques including laser, radiofrequency and focus ultrasound etc.

Dr. Ruby often engaged in cosmetic dermatology communication and academic activities in Korea, China and Taiwan. She is a member of Chinese Dermatologist Association, Chinese Association of Plastics and Aesthetics, China Cross-strait Association of Plastics and Aesthetics.

LicenseLicense no.no. :110110102005455:110110102005455

Currently, he is the Deputy Director of the Department of Gynecological Endocrinology and Reproductive Medicine, The Obstetrics and Gynecology Hospital of Fudan University, the Deputy Chairman of the Youth Committee of the Gynecology Branch of the Chinese Geriatrics Society, the Deputy Chairman of the Youth Committee of the Gynecology Branch of the Chinese Gerontology and Gerontology Society, and the member of the Endocrinology Group of the Gynecology Branch. Member of reproductive Endocrinology Professional Committee of China Medical Education Association, standing member of Menopause Training Center of Reproductive Endocrinology Professional Committee, member of Osteoporosis branch of Shanghai Medical Association, member of Scientific Popularization Branch of Shanghai Medical Doctor Association, member of National Health Science Popularization expert Bank.

Expertise
Minimally invasive treatment of gynecological benign and malignant tumors, including single-port and traditional laparoscopic surgery for uterine fibroids, ovarian cysts, cervical cancer and infertility. Diagnosis and treatment of diseases related to abnormal ovarian function, including polycystic ovary syndrome, premature ovarian failure, menopausal syndrome and menstrual disorders

Dr. Vic YAO currently serves as a Critical Care Medicine specialist in Jiahui International Hospital. Dr. Yao obtained his Doctor degree from Capital Medical University in 2012. From 2012 to 2022, he worded in the Department of critical care medicine of Shandong provincial hospital and completed the standardized training of critical care medicine residents and the standardized training of critical care medicine specialty, until he promoted to deputy chief physician. During this period, he participated in the compilation of two books Neurocritical Care and Practical Clinical Monitoring and Treatment of Acute and Critical Diseases, published 5 articles in Chinese or English core journals, and served as teaching or teaching tasks in National and Provincial critical care bronchoscopy and critical care ultrasound classes for many times, in the meanwhile he served as the secretary of Shandong Critical Care Medicine Quality Control Center. In 2022, Dr. Yao joined Jiahui as a member of the HDU team. Based on clinical front-line work experience and knowledge accumulation, Dr. Yao is familiar with theories and technologies related to intensive care and treatment, including ECMO, CRRT, critical bronchoscopy diagnosis and treatment technology, bedside critical ultrasound technology, hemodynamic monitoring technology, endotracheal intubation and mechanical ventilation, etc. He has dedicated his work to apply advanced critical care medicine related diagnosis and treatment technology to treat critically ill patients in an all-round way.

Dr. Yao is certified in Basic Life Support (BLS), Advanced Cardiac Life Support (ACLS) by American Heart Association (AHA), and the 5C Critical Care Specialist Qualification Certificate issued by the Critical Care Medicine Branch of the Chinese Medical Association.

Dr. Ferris LI is currently the Deputy Chief of Intensive Care Unit (ICU) in JiaHui International Hospital. Dr. Li obtained his Bachelor’s Degree of Clinical Medicine in 2002 and Master’s Degree of Cardiovascular Surgery in 2010 from Shanghai Jiaotong University School of Medicine. He obtained Doctorate Degree in 2022. Before joining Jiahui Health, Dr. Li worked in Shanghai Chest hospital for 18 years and completed residency in intensive care unit in that hospital. In 2012 and 2018, he completed the promotion of attending physician and deputy chief physician. During 2009 to 2021, Dr. Li published 13 articles in core journals, obtained one utility model patent led and participated two projects from National Natural Science Foundation of China, participated in the book of thoracic surgery and served on Critical Care Specialist of Shanghai Medical Association and Critical Care Specialist of Shanghai traditional Chinese Medicine Association. In 2021, Dr. Li joined Jiahui as a member of the HDU team. Dr. Li has mastered the theory and technology of critical care medicine, including perioperative management of cardiothoracic surgery, postoperative complication management and functional rehabilitation, and is responsible for the “three-basic” examination and Cardiopulmonary Resuscitation （CPR）training of the whole hospital.

Dr. Li is certified in Basic Life Support (BLS) and Advanced Cardiac Life Support (ACLS) by American Heart Association (AHA).

Dr. XUAN Linli is currently Chief of Medical Oncology at Jiahui International Cancer Center (JICC). With over 30 years of experience in cancer research and clinical practice, Dr. XUAN possesses extensive expertise in diagnosis and treatment of hematologic and oncologic illness, including cancer risk assessment and reduction.

 
After 6 years of study in Shanghai Medical University, Dr. XUAN furthered her clinical training in the Hematology Division of the Internal Medicine Department at Huashan Hospital Fudan University, under the guidance of Professor DING Xunjie, one of the founding figures of the Hematology Department at Huashan Hospital and a key authority in hematology nationwide. Then in the US, she spent an additional 6 years in residency and fellowship training, including specialization in medical oncology and hematology at the University Hospitals, Case Western Reserve University in Cleveland Ohio. Before joining Jiahui Health, Dr. XUAN practiced medical oncology and hematology in the U.S. for over two decades. She obtained certifications from the American Board of Internal Medicine (ABIM) in Internal Medicine, Medical Oncology, and Hematology. Dr. XUAN is also a member of the American Society of Clinical Oncology (ASCO).

 
With a solid academic foundation, systematic training in both China and the U.S., and years of clinical experience in patient care, Dr. XUAN is well-versed in internationally advanced technologies for cancer prevention, diagnosis, and treatment. She is skilled in managing a variety of oncological and hematological diseases. She is detail-oriented and excels in communication with patients and their families. She firmly believes that cancer treatment planning should involve collaboration between patients, families and other disciplines. Additionally, she prioritizes patients' quality of life and is adept at alleviating suffering through standardized, internationally recognized personalized treatment plans and symptom management.

 
Dr. XUAN’s areas of expertise in hematology and oncology treatment include but not limited to:
-Diagnosis and treatment of solid tumors, particularly all stages of breast cancer, advanced gynecological malignancies, advanced prostate cancer and other urological cancer, colorectal cancer, esophageal and stomach cancer, lung cancer, skin cancers especially melanoma, etc.
-Diagnosis and treatment of hematologic malignancies, especially multiple myeloma and lymphoma, chronic lymphocytic leukemia, myeloproliferative neoplasms.
-Diagnosis and treatment of other hematologic conditions, including anticoagulation therapy, platelet disorder, myelodysplastic syndromes and all causes of anemia.
-Cancer genetics, including cancer risk assessment and risk reduction,
-Palliative care, including pain management and supportive therapy.